Nurix Therapeutics, Inc. Profile Avatar - Palmy Investing

Nurix Therapeutics, Inc.

Nurix Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of small molecule therapies for the treatment of cancer and immune disorders. The company develops NX-2127, an orally available Bruton's t…

Biotechnology
US, San Francisco [HQ]

Government Awards Analysis Beta

Obligations Over-Time

Awards
Obligations

Nurix Therapeutics, Inc. has no obligation with a government/award agency.

Latest Obligations

Contracts
$ 0.0
IDVs
$ 0.0
Direct Payments
$ 0.0
Grants
$ 0.0
Loans
$ 0.0
Other Payments
$ 0.0
vs. Previous FY
Contracts
$ 0.0
IDVs
$ 0.0
Direct Payments
$ 0.0
Grants
$ 0.0
Loans
$ 0.0
Other Payments
$ 0.0

Spending By Type

Awards
Obligations

Nurix Therapeutics, Inc. can't present spending by time.

Get PRO Today

With PRO you will unlock all insights related to government awards of Nurix Therapeutics, Inc..

End of NRIX's Analysis
CIK: 1549595 CUSIP: 67080M103 ISIN: US67080M1036 LEI: - UEI: -
Secondary Listings
NRIX has no secondary listings inside our databases.